Skip to main content

Table 3 Results of the main regression analyses

From: One-year follow-up healthcare costs of patients diagnosed with skin cancer in Germany: a claims data analysis

Parameter

Estimate

Standard error

95% CI

Z

Pr >|Z|

MM, main analysis

 Intercept

7.5284

0.0336

7.4626

7.5942

224.16

 < .0001

 Scr

-0.3563

0.0317

-0.4185

-0.2942

-11.24

 < .0001

 Per

0.8360

0.0317

0.7739

0.8981

26.39

 < .0001

 Scr*Per

-0.1720a

0.0466

-0.2634a

-0.0807a

-3.69

0.0002

 EH

0.1036

0.0061

0.0916

0.1155

17.01

 < .0001

 PBM

0.1391

0.0082

0.1231

0.1551

17.04

 < .0001

NMSC, main analysis

 Intercept

7.3222

0.0142

7.2943

7.3501

514.17

 < .0001

 Scr

-0.2106

0.0132

-0.2364

-0.1847

-15.95

 < .0001

 Per

0.3476

0.0085

0.3310

0.3643

40.95

 < .0001

 Scr*Per

0.0249a

0.0130

-0.0006a

0.0504a

1.92

0.0555

 EH

0.1013

0.0027

0.0960

0.1065

37.95

 < .0001

 PBM

0.1640

0.0031

0.1579

0.1701

52.64

 < .0001

  1. CI Confidence interval, Scr dummy-variable to distinguish between routine SCS that has taken place and no routine SCS, Per dummy-variable to distinguish between pre- and post-observation period, PBM Pharmacy-based Metric, EH Elixhauser Comorbidity Index; Screening*Period denotes the DiD estimator
  2. aDifferences in coefficients between table and text arise as the text reports exact numbers, calculated as ((e^coefficient)-1)*100%